Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (12)
P 4 (2)

Trial Status

Completed10
Unknown8
Active Not Recruiting1
Not Yet Recruiting1
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07337070Not ApplicableActive Not RecruitingPrimary

Chronological Versus Non-chronological Phacoemulsification Training

NCT07550907Not Yet RecruitingPrimary

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

NCT07548294CompletedPrimary

EDOF vs Enhanced vs Monofocal IOLs After Bilateral Cataract Surgery

NCT07517094Completed

Pupillary Dilator Muscle Thickness as a Potential Predictor of Intraoperative Floppy Iris Syndrome

NCT05802550Not ApplicableCompletedPrimary

Metabo-lipidomics of the Ocular Surface for Cataract Surgery

NCT04702802Not ApplicableCompletedPrimary

Study to Evaluate the Safety of the Viscoelastic Substance PRO-149, Compared to Healon® EndoCoat.

NCT07246915Enrolling By InvitationPrimary

Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)

NCT05396547Not ApplicableCompletedPrimary

Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract

NCT05573529Not ApplicableCompletedPrimary

EDOF and Multifocal IOL Study

NCT04050644Phase 4RecruitingPrimary

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

NCT06266962Phase 4Completed

Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome

NCT04262596Not ApplicableCompletedPrimary

Effectiveness of an Interactive Consulting System to Enhance Patients' Decision-making: A Randomized Controlled Trial

NCT04246346Not ApplicableUnknownPrimary

Effectiveness of Using Interactive Consulting System to Enhance Informed Choice

NCT04443101UnknownPrimary

Effective Lens Position After Cataract Surgery

NCT04163926Not ApplicableWithdrawn

Optometric Follow-up After Cataract Surgery

NCT05255796Not ApplicableUnknownPrimary

IOL-capsular Complex After Different Intraocular Lenses Implantation in Patients With High Myopia

NCT05148741CompletedPrimary

Evaluation of Capsular Bag Shape Changes After Plate-haptic Intraocular Lens Implantation by SS-OCT

NCT05028530UnknownPrimary

Correlation Analysis of Lens Nucleus Density and Surgical Parameters Based on Ss-oct and Scheimpflug Technology

NCT04711395UnknownPrimary

The Application of Lens Dysfunction Index (DLI) in the Timing of Age-related Cataract Surgery

NCT03992807Not ApplicableUnknownPrimary

A Decision Aid for Patients With Age-related Cataract

Scroll to load more

Research Network

Activity Timeline